Follow
Richard Mailman
Richard Mailman
University Distinguished Professor and College of Medicine Distinguished Senior Scholar
Verified email at psu.edu
Title
Cited by
Cited by
Year
Functional selectivity and classical concepts of quantitative pharmacology
JD Urban, WP Clarke, M Von Zastrow, DE Nichols, B Kobilka, H Weinstein, ...
Journal of Pharmacology and Experimental Therapeutics 320 (1), 1-13, 2007
13022007
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro, S Renock, E Arrington, LA Chiodo, LX Liu, DR Sibley, ...
Neuropsychopharmacology 28 (8), 1400-1411, 2003
12252003
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes
CP Lawler, C Prioleau, MM Lewis, C Mak, D Jiang, JA Schetz, ...
Neuropsychopharmacology 20 (6), 612-627, 1999
5831999
Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?
RB Mailman, V Murthy
Current pharmaceutical design 16 (5), 488-501, 2010
4112010
Serotonergic basis of antipsychotic drug effects in schizophrenia
JA Lieberman, RB Mailman, G Duncan, L Sikich, M Chakos, DE Nichols, ...
Biological psychiatry 44 (11), 1099-1117, 1998
3061998
Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways
JD Urban, GA Vargas, M Von Zastrow, RB Mailman
Neuropsychopharmacology 32 (1), 67-77, 2007
2692007
Smoking duration, intensity, and risk of Parkinson disease
H Chen, X Huang, X Guo, RB Mailman, Y Park, F Kamel, DM Umbach, ...
Neurology 74 (11), 878-884, 2010
2662010
trans-10, 11-dihydroxy-5, 6, 6a, 7, 8, 12b-hexahydrobenzo [a] phenanthridine: a highly potent selective dopamine D1 full agonist
WK Brewster, DE Nichols, RM Riggs, DM Mottola, TW Lovenberg, ...
Journal of medicinal chemistry 33 (6), 1756-1764, 1990
2501990
AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat
TJ Walsh, HA Tilson, DL DeHaven, RB Mailman, A Fisher, I Hanin
Brain research 321 (1), 91-102, 1984
2501984
GPCR functional selectivity has therapeutic impact
RB Mailman
Trends in pharmacological sciences 28 (8), 390-396, 2007
2402007
Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease
X Huang, H Chen, WC Miller, RB Mailman, JL Woodard, PC Chen, ...
Movement disorders: official journal of the Movement Disorder Society 22 (3 …, 2007
2362007
Simultaneous quantification of dopamine, 5-hydroxytryptaine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with …
CD Kilts, GR Breese, RB Mailman
Journal of Chromatography B: Biomedical Sciences and Applications 225 (2 …, 1981
2201981
Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
CB Nemeroff, D Luttinger, DE Hernandez, RB Mailman, GA Mason, ...
Journal of Pharmacology and Experimental Therapeutics 225 (2), 337-345, 1983
2121983
A selective D-1 dopamine antagonist with potent D-2 behavior actions.
RB Mailman
Eur J Pharmacol 101, 159-160, 1984
1951984
Dihydrexidine, a full dopamine D, agonist, reduces MPTP-induced parkinsonism in monkeys
JR Taylor, MS Lawrence, DE Redmond Jr, JD Elsworth, RH Roth, ...
European journal of pharmacology 199, 389-391, 1991
1841991
Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu‐Asia Aging Study
X Huang, RD Abbott, H Petrovitch, RB Mailman, GW Ross
Movement disorders: official journal of the Movement Disorder Society 23 (7 …, 2008
1762008
Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge
MH Lewis, JP Gluck, AJ Beauchamp, MF Keresztury, RB Mailman
Brain Research 513 (1), 67-73, 1990
1761990
Quantitative susceptibility mapping of the midbrain in Parkinson's disease
G Du, T Liu, MM Lewis, L Kong, Y Wang, J Connor, RB Mailman, X Huang
Movement Disorders 31 (3), 317-324, 2016
1722016
Projection of the prevalence of Parkinson's disease in the coming decades: Revisited
A Rossi, K Berger, H Chen, D Leslie, RB Mailman, X Huang
Movement Disorders 33 (1), 156-159, 2018
1682018
Novel dopamine therapeutics for cognitive deficits in schizophrenia
AFT Arnsten, RR Girgis, DL Gray, RB Mailman
Biological psychiatry 81 (1), 67-77, 2017
1662017
The system can't perform the operation now. Try again later.
Articles 1–20